Page last updated: 2024-10-21

n-methyl-3,4-methylenedioxyamphetamine and Attention Deficit and Disruptive Behavior Disorders

n-methyl-3,4-methylenedioxyamphetamine has been researched along with Attention Deficit and Disruptive Behavior Disorders in 1 studies

N-Methyl-3,4-methylenedioxyamphetamine: An N-substituted amphetamine analog. It is a widely abused drug classified as a hallucinogen and causes marked, long-lasting changes in brain serotonergic systems. It is commonly referred to as MDMA or ecstasy.
3,4-methylenedioxymethamphetamine : A member of the class of benzodioxoles that is 1,3-benzodioxole substituted by a 2-(methylamino)propyl group at position 5.

Attention Deficit and Disruptive Behavior Disorders: Includes two similar disorders: oppositional defiant disorder and CONDUCT DISORDERS. Symptoms occurring in children with these disorders include: defiance of authority figures, angry outbursts, and other antisocial behaviors.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Diamond, GM1
Izzard, MC1
Kedar, T1
Hutlzer, A1
Mell, H1

Other Studies

1 other study available for n-methyl-3,4-methylenedioxyamphetamine and Attention Deficit and Disruptive Behavior Disorders

ArticleYear
Psychological symptoms and drug use severity among Israeli adolescents presenting for outpatient drug abuse treatment.
    Journal of adolescence, 2005, Volume: 28, Issue:4

    Topics: Adolescent; Ambulatory Care; Attention Deficit and Disruptive Behavior Disorders; Depression; Female

2005